Where does Omron Healthcare Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Omron Healthcare Co., Ltd. ranks #902 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Omron Healthcare Co., Ltd. hold?

Omron Healthcare Co., Ltd. holds 499 US utility patents granted between 2015 and 2025, spanning 71 technology areas.

What is Omron Healthcare Co., Ltd.'s Innovation Score?

Omron Healthcare Co., Ltd. has an Innovation Score of 59.8 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Omron Healthcare Co., Ltd. focus on?

Omron Healthcare Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 296 patents, ranking #73 of 7,127 assignees active in that subclass. Grants appear in 71 CPC subclasses total.

Is Omron Healthcare Co., Ltd.'s patent grant rate increasing or decreasing?

Omron Healthcare Co., Ltd.'s recent grant velocity is +42% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Omron Healthcare Co., Ltd.'s patents?

Omron Healthcare Co., Ltd.'s patents average 7.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Omron Healthcare Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Omron Healthcare Co., Ltd.

USPTO PatentsView assignee record - 499 granted patents across 71 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Omron ranks #902 of 49,997 tracked US assignees by granted-patent volume, with 499 patents across 71 technology areas.

#902
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.8/100): 7.0
avg claims per patent: +42%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R902 · Foreign Corporation #902 · 499 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MID 499 grants
TOP-DECILE #902/49,997
PHOTO-FINISH Dalian University…
CPC-WIDE A61B · 71 areas
INNOV-PAR 59.8/100
CLAIMS-SPARSE 7.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +42% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dalian University of Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Omron’s 59.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 21.5 pts (36%) Velocity 9.1 pts (15%) Breadth 25.0 pts (42%) Claim depth 4.2 pts (7%)

Qualcomm Incorporated · highest

85
Omron Healthcare · this assignee

60
Pfizer · near

60
Repligen · near

60
Triad National… · near

60
Yara International ASA · near

60
3D Lighting… · lowest

7

What this shows Omron's Innovation Score is 59.8/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Omron?

Each dot is one of Omron’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Omron’s own 7.0 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Omron vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Omron's grant cadence moved

Between 2020–2024, Omron Healthcare Co., Ltd. received 282 grants versus 199 in 2015–2019 (+42% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2022 at 68 grants and bottomed in 2017 at 24. Lead class A61B accounts for 59.3% of the portfolio across 71 subclasses. Volume neighbours: China Petroleum & Chemical Corporation (#898) and Wilus Institute OF Standards AND Technology Inc. (#906).

Omron's three-year grant acceleration

From 2019–2021 to 2022–2024, Omron Healthcare Co., Ltd. moved from 134 to 183 grants (1.37x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #556. See the growth leaderboard.

China Petroleum &…

500
United Parcel Ser…

500
Dalian University…

499
NHK Spring

499
Omron Healthcare ◀

499
Eastman Chemical

498
University OF Mar…

497
Symbol

496
Wilus Institute O…

496

What this shows Omron holds 499 patents at rank #902, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Omron

By rank, the assignees closest to #902 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Omron's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Omron, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Omron ranks #73 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (60 here).

Pfizer Inc. 60 Triad National Security, LLC 60 Yara International ASA 60 Repligen Corporation 60

Similar claim depth

Nearest assignees by average claims per patent (7.0 here).

Jtekt Corporation 7.0 avg Ulvac, Inc. 7.0 avg Woodpeckers, LLC 7.1 avg Mitsubishi Paper Mills Limited 7.1 avg

Omron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Omron Healthcare Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	55	11.0%
2016	46	9.2%
2017	24	4.8%
2018	39	7.8%
2019	35	7.0%
2020	48	9.6%
2021	51	10.2%
2022	68	13.6%
2023	48	9.6%
2024	67	13.4%
2025partial year	18	3.6%

Which technologies does Omron Healthcare Co., Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 296

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 48

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 27

G06F - Electric Digital Data Processing 23

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 21

A46B - Brushes 18

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 15

H04W - Wireless Communication Networks 13

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 13

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 13

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 9

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 8

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 7

Top 15 of 71 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Omron Healthcare Co., Ltd.'s patent record in context - here's where to go next.

Omron Healthcare Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 59.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #902 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Omron Healthcare Co., Ltd. against China Petroleum & Chemical Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.